A carregar...

Reporting of Incidence and Outcome of Bone Metastases in Clinical Trials Enrolling Patients with Epidermal Growth Factor Receptor Mutated Lung Adenocarcinoma—A Systematic Review

SIMPLE SUMMARY: Around 30–60% of the patients with lung cancer develop bone metastases, which are associated with decreased survival, bone pain, and skeletal-related events such as need for radiation. Patients with an epidermal growth factor mutation (EGFR), a subgroup of the patients with lung canc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Brouns, Anita, Dursun, Safiye, Bootsma, Gerben, Dingemans, Anne-Marie C., Hendriks, Lizza
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8267949/
https://ncbi.nlm.nih.gov/pubmed/34201833
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13133144
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!